Search - tctmd.com

Displaying 661 - 680 of 1004

Sort: Relevancy | Date

News Daily News

APPOSITION II Published: Self-Expanding Stent Performs Well in STEMI Patients

December 17, 2012

News Daily News

Un Meta Análisis estudia el Bypass frente a la Terapia Endovascular en las Lesiones Femoropoplíteas

L.A. McKeown

December 12, 2012

News Daily News

Meta-analysis Looks at Bypass vs. Endovascular Therapy for Femoropopliteal Lesions

L.A. McKeown

December 12, 2012

News Industry News

CID Spa releases the NEXT Study 24-months data on its Cre8™ DES at TCT 2012

December 10, 2012

News Daily News

PACIFIER Published: Drug-Eluting Balloon Helps Treat Femoropopliteal Lesions

Caitlin E. Cox

December 09, 2012

News Daily News

Extended Dual Antiplatelet Therapy Lowers Death, MI Rates in DES Patients

Jason Kahn

December 05, 2012

News Industry News

First Patient Enrolled in the Boston Scientific Multicenter Study of the SYNERGY™ Coronary Stent System Featuring a Bioabsorbable Polymer Coating

November 29, 2012

News Daily News

Meta-analysis Questions Benefit of Longer Dual Antiplatelet Therapy Post-PCI

November 28, 2012

News Daily News

Meta-análisis cuestiona beneficio de la terapia antiplaquetaria doble extendida después la PCI

November 28, 2012

News Daily News

Zilver Stent Seen as Welcome Addition to PAD Armamentarium

L.A. McKeown

November 25, 2012

News Daily News

Stent Zilver parece ser una adición bienvenida al arsenal de PAD

L.A. McKeown

November 25, 2012

News Daily News

Study Shows Impact of Public Health Communication on Clopidogrel Use Post DES

November 20, 2012

News Daily News

BELLO: Drug-Coated Balloons Take on De Novo Lesions vs. DES

Caitlin E. Cox

November 15, 2012

News Daily News

BELLO: Balones recubiertos de Fármacos contra Lesiones De Novo frente a SLF

Caitlin E. Cox

November 15, 2012

News Industry News

Cook Medical’s Zilver® PTX® Earns FDA Approval As First Drug-Eluting Stent in U.S. to Treat Peripheral Arterial Disease

November 14, 2012

Presentation

BELLO: Paclitaxel Drug-Eluting Balloons vs. Paclitaxel-Eluting Stents in Small Coronary Vessels

Presenter: A. Latib

November 13, 2012

News Conference News AHA 2012

ARCTIC: Bedside Platelet Monitoring Fails to Help DES Patients

Jason Kahn

November 04, 2012

News Conference News TCT 2012

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

October 31, 2012

News Industry News

Boston Scientific Receives CE Mark Approval for the SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System, Featuring A Novel Bioabsorbable Polymer Coating

October 31, 2012

News Industry News

Tryton Presents Positive Data from More Than 900 Patients at TCT 2012 Conference in Miami

October 29, 2012

Advertisement

APPOSITION II Published: Self-Expanding Stent Performs Well in STEMI Patients

Un Meta Análisis estudia el Bypass frente a la Terapia Endovascular en las Lesiones Femoropoplíteas

Meta-analysis Looks at Bypass vs. Endovascular Therapy for Femoropopliteal Lesions

CID Spa releases the NEXT Study 24-months data on its Cre8™ DES at TCT 2012

PACIFIER Published: Drug-Eluting Balloon Helps Treat Femoropopliteal Lesions

Extended Dual Antiplatelet Therapy Lowers Death, MI Rates in DES Patients

First Patient Enrolled in the Boston Scientific Multicenter Study of the SYNERGY™ Coronary Stent System Featuring a Bioabsorbable Polymer Coating

Meta-analysis Questions Benefit of Longer Dual Antiplatelet Therapy Post-PCI

Meta-análisis cuestiona beneficio de la terapia antiplaquetaria doble extendida después la PCI

Zilver Stent Seen as Welcome Addition to PAD Armamentarium

Stent Zilver parece ser una adición bienvenida al arsenal de PAD

Study Shows Impact of Public Health Communication on Clopidogrel Use Post DES

BELLO: Drug-Coated Balloons Take on De Novo Lesions vs. DES

BELLO: Balones recubiertos de Fármacos contra Lesiones De Novo frente a SLF

Cook Medical’s Zilver® PTX® Earns FDA Approval As First Drug-Eluting Stent in U.S. to Treat Peripheral Arterial Disease

BELLO: Paclitaxel Drug-Eluting Balloons vs. Paclitaxel-Eluting Stents in Small Coronary Vessels

ARCTIC: Bedside Platelet Monitoring Fails to Help DES Patients

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

Boston Scientific Receives CE Mark Approval for the SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System, Featuring A Novel Bioabsorbable Polymer Coating

Tryton Presents Positive Data from More Than 900 Patients at TCT 2012 Conference in Miami

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content